White Mulberry DNJ.
White Mulberry DNJ supplementation for targeted health support. DNJ blocks alpha-glucosidase, slowing carbohydrate breakdown and absorption. This reduces post-meal blood sugar spikes.
Reviewed March 2026
- Category
- Antioxidant
What White Mulberry DNJ is, and what it does.
- Does it work
- Actual mechanism with clinical backing. Works for carb-heavy meals. Not dramatic but real effect.
- How much to take
- 500-1000mg mulberry extract standardized to DNJ, or 1-3mg DNJ, taken before carb-containing meals.
- Time to feel it
- It acts on the meal it is taken with, so the glucose curve changes the first time you use it. Longer measures need weeks of taking it before carbohydrate meals.
- The first dose
- May notice less blood sugar spike after high-carb meal. Some experience GI effects.
- With regular use
- Better post-meal glucose control. Potential A1c improvements with consistent use.
- How well tolerated
- Generally well tolerated. GI effects possible.
- How it feels
- Subtle. Less carb crash. More stable energy after meals.
- The overlooked benefit
- Timing is the whole game. Taken away from carbohydrate it has nothing to act on, because it works at the brush border while sugars are being split.
1 to 6mg a day is where White Mulberry DNJ works.
Source: Kimura et al. (2007) J Agric Food Chem; DNJ blood sugar studies
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Reduces post-meal glucose spikeMultiple clinical trials
- Alpha-glucosidase inhibitionBiochemical studies
- Supports blood sugar managementClinical evidence
Questions people ask about White Mulberry DNJ.
- How does it work?
- Blocks the enzyme that breaks down complex carbs into simple sugars. Less sugar absorption means lower blood glucose spike.
- Can I eat whatever I want?
- No. It reduces the impact of carbs, doesn't eliminate it. Still need overall good diet.
- Will it cause gas?
- Possibly. Undigested carbs reach the colon and get fermented. Start with lower doses.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
1-deoxynojirimycin is a sugar-mimic that competitively inhibits intestinal alpha-glucosidase, slowing starch breakdown before absorption. Berberine works after absorption through AMP-activated protein kinase, so the two stages are distinct.
Gymnemic acids interfere with intestinal glucose transport and sweet taste signalling. DNJ blocks the enzyme that releases that glucose in the first place, so digestion and transport are both slowed.
Corosolic acid supports GLUT4 movement to the cell membrane and glucose entry into tissue. DNJ acts entirely in the gut lumen, so the two sit at opposite ends of the same pathway.
Cinnamon polyphenols support normal insulin receptor signalling once glucose has been absorbed. DNJ works before that point by slowing carbohydrate digestion.
Chromium supports insulin receptor signalling through chromodulin at the cell membrane. That post-absorptive role does not overlap with DNJ's enzyme inhibition in the gut.
Bitter melon constituents act on cellular glucose uptake and hepatic glucose handling. DNJ acts only in the intestinal lumen, so the sites of action are separate.
Glucomannan gel slows gastric emptying and the diffusion of sugars to the absorptive surface. Combined with DNJ's enzyme inhibition, the post-meal glucose rise is slowed by two independent means.
Psyllium forms a viscous gel that slows carbohydrate diffusion in the small intestine. It also slows the uptake of co-ingested minerals and actives, so dosing windows need attention.
Lipoic acid is the cofactor for pyruvate dehydrogenase and supports normal glucose oxidation inside the mitochondrion. That intracellular step sits downstream of everything DNJ does in the gut.
Inositol phosphoglycans carry the insulin signal from the receptor into the cell. DNJ never reaches that step, acting instead on carbohydrate digestion, so the two cover different stages.
Fenugreek galactomannan raises the viscosity of gut contents while 4-hydroxyisoleucine supports normal insulin release. The viscosity effect adds directly to DNJ's slowing of starch digestion.
Alpha-glucosidase inhibition pushes more undigested carbohydrate into the colon for bacterial fermentation. Adding resistant starch raises that fermentable load further, and gas and bloating follow.
Catechins slow the alpha-amylase step that breaks starch into oligosaccharides, while 1-deoxynojirimycin acts one step later on the brush border alpha-glucosidases. The two therefore constrain carbohydrate digestion at different points in the same sequence. Both need to be taken with the carbohydrate-containing meal to do anything. Slower digestion means more carbohydrate reaching the colon, so gas and bloating are the expected trade-off.
Guar gum raises the viscosity of stomach and intestinal contents, which slows how fast carbohydrate reaches the absorptive surface. DNJ acts at that surface by holding up disaccharide hydrolysis. The two mechanisms are independent and both flatten the rate at which glucose appears in blood. Adequate fluid intake matters with any viscous fibre.
Partially hydrolysed guar gum retains fermentability with much lower viscosity than the intact gum, so it is easier to formulate into drinks. Its slowing effect on gastric emptying complements the brush border action of DNJ. It also feeds colonic bacteria, which is relevant since alpha-glucosidase inhibition pushes more carbohydrate into the colon. The pairing may make that shift more comfortable rather than less.
Oat beta-glucan slows the rate at which digested carbohydrate reaches the intestinal wall by raising viscosity. DNJ works on the hydrolysis step itself. Together they act on rate of appearance from two separate angles. Both need to be present in the same meal to matter.
Pectin forms a gel that slows gastric emptying and the diffusion of sugars to the absorptive surface. Paired with an alpha-glucosidase inhibitor, the rate of glucose appearance is constrained at two independent points. The effect depends on taking enough pectin with the meal. Digestive tolerance sets the practical ceiling.
Alpha-glucosidase inhibition means some carbohydrate escapes small intestinal digestion and reaches the colon, where it is fermented. Inulin adds to that fermentable load. This can be intended, since short chain fatty acid production is the outcome, but it also compounds the gas and bloating that follow. Anyone combining them should build up the dose gradually.
A protein preload slows gastric emptying and triggers incretin secretion, both of which flatten the rise in blood glucose after a carbohydrate meal. DNJ works separately by holding up disaccharide breakdown at the brush border. The two effects are mechanistically distinct and act on the same post-meal window. This is a meal-sequencing point as much as a supplement one.
Because alpha-glucosidase inhibition sends more carbohydrate into the colon, the composition of the colonic microbiota shapes what happens to it and how much gas is produced. Animal work with mulberry leaf DNJ reports shifts in microbiota composition alongside the digestive changes. Whether a specific probiotic makes the shift more comfortable in people is not established. The connection is recorded at mechanism level.
Carbohydrate arriving in the colon after alpha-glucosidase inhibition becomes substrate for resident lactic acid bacteria. Which species dominate influences the fermentation products and the gas volume. This is a plausible route by which a specific strain could alter tolerability. It has not been demonstrated for this combination in people.
Supplemental amylase speeds the breakdown of starch into disaccharides, increasing the substrate load arriving at the brush border. That works against the intent of an alpha-glucosidase inhibitor taken with the same meal. The two are pulling in opposite directions on carbohydrate digestion rate. Anyone taking a digestive enzyme blend at meals should know this before adding mulberry extract.
Broad enzyme blends generally include amylase, and some include glucoamylase, which performs the same reaction DNJ inhibits. Taken in the same meal the blend directly opposes the intended effect. Separating them across meals resolves it. This is the clearest antagonistic pairing for this ingredient.
Iminosugars act on brush border glycosidases broadly rather than on a single enzyme, so the same class of inhibition that slows sucrase and maltase may touch other disaccharidases. Someone relying on supplemental lactase for a dairy-containing meal should be aware of the overlap. The extent of any effect on lactase specifically is not quantified here. Flagged rather than asserted.
Acetic acid taken with a meal slows gastric emptying and has been described as reducing disaccharidase activity. That overlaps and adds to the alpha-glucosidase inhibition from DNJ. Both need to be taken with the meal rather than after it. Dental enamel exposure is the practical caution with any acidic liquid.
Magnesium serves as the counter-ion for ATP in hexokinase and downstream kinase reactions, so it participates in normal glucose utilisation once glucose is inside the cell. DNJ acts entirely in the gut lumen and never gets that far. The two therefore address different ends of the same physiology without overlapping. The cofactor role is textbook; a combination effect has not been measured.
Nothing specific on file for White Mulberry DNJ. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What White Mulberry DNJ actually does.
1-deoxynojirimycin is an iminosugar in which the ring oxygen of a glucose-like sugar is replaced by nitrogen, giving a molecule that fits the active site of alpha-glucosidase enzymes but cannot be cleaved.
Because it occupies the enzyme site without being hydrolysed, 1-deoxynojirimycin acts as a competitive inhibitor of the brush border alpha-glucosidases sucrase, maltase and isomaltase, slowing the final step that releases free glucose from disaccharides.
The inhibition happens in the intestinal lumen at the brush border, so the compound has to be present at the same time as the carbohydrate; taken away from a meal it has nothing to act on.
Slowing disaccharide hydrolysis spreads glucose release over a longer stretch of intestine rather than removing carbohydrate from the diet, so total energy absorbed changes far less than the shape of the post-meal glucose curve does.
Where White Mulberry DNJ comes from.
It starts with leaves picked from white mulberry trees, which are washed, dried and ground up. Because the active compound dissolves easily in water, hot water or a water and alcohol mix is enough to pull it out. The liquid is filtered and run through a resin that grabs the compound and lets the plain sugars and green pigment wash away. What is left gets tested to confirm the strength, dried onto a powder carrier and packed into capsules. The same molecule can also be grown by bacteria in a tank instead of coming from leaves.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
White mulberry leaves are picked from cultivated trees, with leaf age and season affecting 1-deoxynojirimycin content, then washed and dried at controlled temperature.
Dried leaf is milled and extracted with hot water or a water-ethanol mixture; the iminosugar is highly water soluble, so aqueous solvent recovers it efficiently.
The extract is filtered and passed over ion exchange resin, which retains the nitrogen-containing iminosugar and separates it from sugars and much of the pigment load.
1-deoxynojirimycin is quantified by HPLC, usually after derivatisation since the molecule lacks a strong chromophore, and lots are blended or diluted onto a carrier to reach the stated percentage.
The standardised concentrate is spray dried onto a carrier such as maltodextrin or rice flour and filled into capsules or tablets.
Getting White Mulberry DNJ from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Pooled human and mechanistic evidence on mulberry extract points to modest modulation of metabolic markers such as blood sugar and blood lipids.Meta-analysis. Yu et al., 2025 (International journal of molecular sciences). PMID 40943306 ↗
- A systematic review of Morus alba studies in adults with elevated blood sugar readings found the available human trials generally reported lower glucose readings, with small study sizes limiting how firm the picture is.Systematic review. Morales Ramos et al., 2021 (F1000Research). PMID 34912543 ↗
- Mulberry leaf extract taken with four common dietary carbohydrates lowered their measured glycemic index, meaning blood sugar rose less steeply after the meal.Randomised trial. Wang et al., 2018 (Medicine). PMID 30142838 ↗
- A mulberry-containing supplement taken before a carbohydrate-rich meal lowered the post-meal peaks in both blood glucose and insulin compared with placebo.Randomised trial. Venugopal et al., 2024 (Nutrients). PMID 39064681 ↗
- Mulberry leaf extract at three dose levels lowered the measured glycaemic index of white bread in a dose-related way; glycaemic index is a post-meal response marker, not a clinical outcome.Randomised trial. Ding F et al., 2023 (PLoS One). PMID 37561734 ↗
- A multi-plant extract formulation that includes mulberry lowered post-meal glucose and insulin peaks in two randomised studies; because the formulation carries several extracts, the result cannot be attributed to mulberry alone.Randomised trial. Adamska-Patruno E et al., 2018 (Nutrients). PMID 30044398 ↗
- A review of deoxynojirimycin and Morus alba summarises the chemistry, sources and reported activities of the iminosugar and names alpha-glucosidase inhibition as its principal described mechanism.Narrative review. Tricase AF et al., 2025 (Molecules). PMID 40807388 ↗
- A review argues that mulberry leaf activity reflects several constituents acting together rather than 1-deoxynojirimycin alone, and sets out a translational research agenda; it summarises other work rather than measuring an effect.Narrative review. Chen J et al., 2026 (Frontiers in Nutrition). PMID 42051334 ↗
- A review catalogues the constituent classes of mulberry and the agronomic conditions that shape them, which is relevant to why extract composition varies between lots.Narrative review. Feng L et al., 2026 (International Journal of Molecular Sciences). PMID 41977124 ↗
- An update reviewing white mulberry plant extracts summarises the reported effects on lipid and vascular markers; the underlying studies are mostly small and the review does not measure an effect itself.Narrative review. Trimarco V et al., 2025 (Nutrients). PMID 40732887 ↗
- A phytochemical survey of four medicinal plants profiles bioactive compounds and names mulberry among the plants with reported carbohydrate-handling activity; the characterisation is chemical rather than clinical.Narrative review. Al Raish SM et al., 2025 (Biology). PMID 41007291 ↗
- Mulberry leaf supplementation improved glycaemic markers but the authors did not detect changes in renal or cardiovascular markers in a rodent model with elevated blood pressure; the null is a failure to detect a difference, not evidence that none exists.Animal study. Gryn-Rynko A et al., 2026 (Journal of Physiology and Pharmacology). PMID 42272281 ↗
- 1-deoxynojirimycin from mulberry leaves changed measures of gut digestion and shifted microbiota composition in geese, consistent with more carbohydrate reaching the hindgut.Animal study. Hou Q et al., 2020 (Poultry Science). PMID 33142503 ↗
- Dietary mulberry leaf 1-deoxynojirimycin shortened villus height while improving intestinal barrier markers in a livestock model; these are tissue and barrier markers, not clinical outcomes.Animal study. Li S et al., 2024 (Animal Bioscience). PMID 39210821 ↗
These are the studies our verdict leans on, chosen from the 72 we read for White Mulberry DNJ. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.